Member Info for Energyshares

Swoop working with the A.rse bottom trying to spread fear.
FFS

Scrapping the bottom again.

Richard Hughes owner of Medusa19 reposting Avacta message about Fiona McLaughlin presenting at ICPO on LinkedIn.

Could Medusa and Avacta still be working together.
Avacta just need a manufacturer to complete their diagnostics supply chain.
Medusa ??

Reading this Affyxell is far more advanced than anyone has realised.

AffyXell“, by AffyXell Therapeutics, is being developed in the following stages to ensure mass production in highly consistent quality. A parental cell bank was manufactured with DW-MSC differentiated from PSC, and the AffyXell bank into which the Affimer gene was introduced through a viral vector are separately manufactured. AffyXell cell bank is stored at cryogenic temperature, and each of 1 vial of cell bank is thawed for batch production. The fill-finish engineered products are cryopreserved and packaged. The final products are distributed globally using cryogenic temperature logistics system, and each dose is thawed at each hospital and administered to patients immediately.

http://affyxell.com/en/technology/tech.php

This is the government project.

https://hexarhc.com/?p=5517&lang=en

The Gimhae Biomedical Promotion Agency shows here in the partners tab.

http://affyxell.com/en/media/partner.php

Apre
I think we will see rockets from this company in the next few years.

I wonder what the government project is did this get a RNS.

May
Selected for a government project of the Ministry of Trade, Industry and Energy
April
Selected as a target of two by the Korean Fund for Regenerative Medicine(KFRM) (3.6 billion won)

Current CEO of Daewoong Pharmaceutical on the board

Looks like the venture capitalists have places on the board also.

Jeong Hoon Kang
Samsung Venture Investment

Jae Young Lee
Senior associate of Shinhan Venture Investment

Alastair Smith & Fiona Mclaughlin added to Affyxell board of directors

http://affyxell.com/en/company/people.php

Yep whaler committee still meeting.

https://m.youtube.com/watch?v=BLpQMskLK2M

84 days into Cohort 4 , Just waiting on this data collection.

The rest of the trial would all be collated and finalised ask the FDA on what grounds and data they passed ODD.

Just sit and wait.
GLA

Wyn trying to turn the thread about him again. FFS

Tree shake hold tight
GLA

Avacta trial of AVA6000 to advance to phase 1b.

PK data exceeds expectations in AVA6000 trial.

Revolutionising the treatability of solid tumours.

Boom off to the moon.

:):):) GLA

1st Sep
Phase I clinical study of AVA6000 to advance to the fourth cohort.
5th Sep
AVA6000 receives Orphan Drug Designation from the US Food and Drug Administration.

These two RNS’s defiantly linked.

I suspect Avacta passed data results of third cohort to FDA which influenced their quick decision.

Could the unexpected happen when they see cohort 4 results.

When can I apply for FDA fast track?

The request can be initiated at any time during the drug development process. FDA will review the request and make a decision within sixty days based on whether the drug fills an unmet medical need in a serious condition

78 fast track requests in 2022 so far 22 granted.

https://www.fda.gov/media/95286/download

GLA

Myballgoinghomefortea

Touk do you think they could raise £55 million bond without any high-level due diligence.
It works just waiting for the RNS to see how good it is.

Wonder how II presentation has gone today, Little bit of rise in last half hour do they like what they are hearing…

GLA

Acquisition of Launch Diagnostics……Complete

Management Subscription Shares……Complete

Convertible Bond Offering …..Complete

II’s Placing Shares…Complete

Open offer to PI’s and excess money returned ….Complete

DE4 further than DE3 could be Complete

PK Data due any day

Capital Access Group II’s meeting tomorrow

We are delighted to be appointed by @avacta. Avacta’s mission is to shape the future of medicine, developing novel cancer therapies and diagnostics with their proprietary Affimer® and pre|CISION™ platforms. We look forward to working with the team to develop their IR strategy.

RNS tomorrow ;)

Look at every big rise on AIM always after massive news from a RNS.

The way the PI’s get s.hafted is they are locked out getting a trade before II’s have filled their boots.

It’s the same the other way remember the LFT shambles II’s out first PI’s locked out.

All I’m saying it would be a brave man woman or it, to trade this stock this near to news.

Timmy
So II’s will get to know before everyone else isn’t that inside trading.

I thought we all find out the same time through a RNS.